Blackstone Life Sciences VI (LUX) SCSp — Form D

Blackstone Life Sciences VI (LUX) SCSp of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-12-17. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Julie ConstableExecutive OfficerNew York, NY
Tabea G HsiExecutive OfficerNew York, NY
Natacha G JamarExecutive OfficerNew York, NY
Eric LiawRelated PersonNew York, NY
Christopher StrianoRelated PersonNew York, NY
Joseph BarattaExecutive OfficerNew York, NY
Joseph BarattaRelated PersonNew York, NY
Alicia NovakExecutive OfficerNew York, NY
Alicia NovakRelated PersonNew York, NY
Chris G PlaccaExecutive OfficerNew York, NY
Nentcho G NentchevExecutive OfficerNew York, NY
n/a BXLS VI L.L.C.PromoterNew York, NY
n/a BXLS VI L.L.C.Related PersonNew York, NY
Mathias G FavettoExecutive OfficerNew York, NY
Elsa G GelinExecutive OfficerNew York, NY
n/a Blackstone Life Sciences Associates VI (LUX) S.a r.l.PromoterGrand Duchy of Luxembourg, N4
n/a Blackstone Life Sciences Associates VI (LUX) S.a r.l.Related PersonGrand Duchy of Luxembourg, N4
n/a Blackstone Life Sciences Associates VI L.P.PromoterNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.Related PersonNew York, NY
Victoria G PortnoyExecutive OfficerNew York, NY
Nicholas G GalakatosExecutive OfficerNew York, NY
Robert G LiptakExecutive OfficerNew York, NY
Nentcho NentchevRelated PersonNew York, NY
Omar RehmanRelated PersonNew York, NY
Robert LiptakRelated PersonNew York, NY

Other filings by this issuer (3)

FiledFormOfferingSold
2026-04-02D/A$6.3B$6.3B
2025-12-09D/A$3.6B
2025-10-08D/A$3.3B

More